In malignant tumors, including liver cancer, pancreatic cancer, and cholangiocarcinoma, the expression level of HAT1 was significantly elevated, which suggested that HAT1 was closely related to tumorigenesis 16. This evidence concerns the gene HAT1 and cholangiocarcinoma.